CymitQuimica logo

CAS 1345973-50-3

:

N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide

Description:
N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide, identified by its CAS number 1345973-50-3, is a synthetic compound that belongs to the class of indole derivatives. This substance is characterized by its unique structure, which includes an adamantyl group and a pentyl chain attached to the indole core. The presence of the adamantyl moiety contributes to its lipophilicity, potentially influencing its interaction with biological membranes and receptors. This compound has garnered interest in the field of pharmacology, particularly for its potential effects on the endocannabinoid system, as it may act as a cannabinoid receptor agonist. Its stability, solubility, and bioavailability are important factors that determine its efficacy in biological systems. Additionally, the compound's synthesis and characterization involve various organic chemistry techniques, ensuring purity and structural integrity. As with many synthetic cannabinoids, research into its pharmacological properties and safety profile is ongoing, highlighting the need for careful evaluation in both laboratory and potential therapeutic contexts.
Formula:C24H32N2O
InChI:InChI=1S/C24H32N2O/c1-2-3-6-9-26-16-21(20-7-4-5-8-22(20)26)23(27)25-24-13-17-10-18(14-24)12-19(11-17)15-24/h4-5,7-8,16-19H,2-3,6,9-15H2,1H3,(H,25,27)
InChI key:InChIKey=MDJYHWLDDJBTMX-UHFFFAOYSA-N
SMILES:N(C(=O)C=1C=2C(N(CCCCC)C1)=CC=CC2)C34CC5CC(C3)CC(C4)C5
Synonyms:
  • Apica
  • SDB 001
  • 1H-Indole-3-carboxamide, 1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-
  • 1-Pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indole-3-carboxamide
  • N-(1-Adamantyl)-1-pentyl-1H-indole-3-carboxamide
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • APICA
    Biosynth
    + Info

    APICA

    Controlled Product
    CAS:
    APICA is an indole-based synthetic cannabinoid drug that acts as a strong agonist at the cannabinoid receptors CB1 and CB2 (EC50= 34 nM and EC50 = 29 nM, respectively)1,2. In experimental mice models, it shows less potency when compared to other full synthetic cannabinoid receptor agonists such as JWH-018, but more potency when compared to its indazole derivative APINACA and Δ9-THC. In vivo effects are thought to be similar to Δ9-THC, but have yet to be extensively validated. However, dose-dependent cognitive impairment and sedation were observed in vivo3.
    Purity:Min. 95%

    Ref: 3D-CA175123

    1mg
    307.00€
    5mg
    1,033.00€
    10mg
    1,557.00€